1. Anversa, P. and Sonnerblick, E.H. (1990) Ischemic cardiomyopathy: pathophysiologic mechanisms. Prog. Cardiovasc. Dis. 33, 49–70.
2. Harada, K., Futaka, Y., Miwa, A., Kaneta, S., Fukushima, H. and Ogawa, N. (1993) Effect of KRN 2391, a novel vasodilator, on various experimental anginal models in rats. Jpn. J. Pharmacol. 63, 35.
3. Suchalatha, S., Thirugnanasambantham, P., Maheswaran, E. and Shyamala Devi, C.S. (2004) Role of Arogh, a polyherbal formulation to mitigate oxidative stress in experimental myocardial infarction. Indian J. Exp. Biol. 42(2), 224–226.
4. King, J. (1959). A routine method for the estimation of lactate dehydrogenase activity. J. Med. Lab. Techn. 67, 265–272.
5. Okinaka, S., Kumagai, H., Ebashi, E., Sugaita, M. and Momoi, Y. (1961) Serum creatine phosphokinase activity in progressive muscular dystrophy and neuromuscular disease. Arch. Neurol. 4, 520–526.